SEC Info  
    Home      Search      My Interests      Help      Sign In      Please Sign In

Advanced Biomedical Technologies Inc. – ‘10KSB’ for 10/31/07 – EX-31.1

On:  Tuesday, 1/29/08, at 4:50pm ET   ·   For:  10/31/07   ·   Accession #:  1002014-8-69   ·   File #:  333-139986

Find Words in Filings emoji
 
  in    Show  and   Hints

  As Of                Filer                Filing    For·On·As Docs:Size              Issuer               Agent

 1/29/08  Advanced Biomedical Techs Inc.    10KSB      10/31/07    6:570K                                   Law Office of Con… PS/FA

Annual Report — Small Business   —   Form 10-KSB
Filing Table of Contents

Document/Exhibit                   Description                      Pages   Size 

 1: 10KSB       Geostar Mineral Corporation Form 10-Ksb for 2007    HTML    294K 
 2: EX-14.1     Code of Ethics                                      HTML     36K 
 3: EX-31.1     Sarbanes-Oxley Section 302 Certification of CEO     HTML     13K 
                          and CFO                                                
 4: EX-32.1     Sarbanes-Oxley Section 906 Certification of CEO     HTML      9K 
                          and CFO                                                
 5: EX-99.2     Audit Committee Charter                             HTML     27K 
 6: EX-99.3     Disclosure Committee Charter                        HTML     17K 


EX-31.1   —   Sarbanes-Oxley Section 302 Certification of CEO and CFO


This exhibit is an HTML Document rendered as filed.  [ Alternative Formats ]



  Sarbanes-Oxley Section 302 Certification of CEO and CFO  

Exhibit 31.1

SARBANES-OXLEY SECTION 302(a) CERTIFICATION

I, Andriy Protskiv, certify that:

1.     

I have reviewed this 10-KSB for the year ending October 31, 2007 of Geostar Mineral Corporation.;

 
2.     

Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;

 
3.     

Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report;

 
4.     

I am responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) for the registrant and have:

 
  a.     

Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;

 
  b.     

Evaluated the effectiveness of the registrant's disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and

 
  c.     

Disclosed in this report any change in the registrant's internal control over financial reporting that occurred during the registrant's most recent fiscal quarter (the registrant's fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant's internal control over financial reporting; and

 
5.     

I have disclosed, based on my most recent evaluation of internal control over financial reporting, to the registrant's auditors and the audit committee of the registrant's board of directors (or persons performing the equivalent functions):

 
  a.     

All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant's ability to record, process, summarize and report financial information; and

 
  b.     

Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant's internal control over financial reporting.

 
Date: January 29, 2008  ANDRIY PROTSKIV
  Andriy Protskiv 
  Principal Executive Officer and Principal Financial Officer 
 
 



Dates Referenced Herein

This ‘10KSB’ Filing    Date    Other Filings
Filed on:1/29/08None on these Dates
For Period End:10/31/07
 List all Filings 
Top
Filing Submission 0001002014-08-000069   –   Alternative Formats (Word / Rich Text, HTML, Plain Text, et al.)

Copyright © 2024 Fran Finnegan & Company LLC – All Rights Reserved.
AboutPrivacyRedactionsHelp — Fri., May 17, 12:55:54.1pm ET